|
SNRNP48 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.17490486626093E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.287400E-01 |
| Stage1-vs-Stage3 |
6.424100E-02 |
| Stage1-vs-Stage4 |
4.626300E-02 |
| Stage2-vs-Stage3 |
7.269900E-02 |
| Stage2-vs-Stage4 |
3.135500E-02 |
| Stage3-vs-Stage4 |
6.079600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.71189999637656E-08 |
| Normal-vs-Asian |
2.32229790952942E-11 |
| Caucasian-vs-AfricanAmerican |
4.604800E-01 |
| Caucasian-vs-Asian |
1.728380E-01 |
| AfricanAmerican-vs-Asian |
8.248200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
5.520600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.215200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.817400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.202200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.030600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.503040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.924000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.790400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.849400E-04 |
| Classical-VS-Follicular |
5.257200E-01 |
| Classical-VS-Other |
9.831800E-01 |
| Classical-VS-Normal |
5.50670620214078E-14 |
| Tall-VS-Follicular |
1.998630E-03 |
| Tall-VS-Other |
3.731400E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
8.342000E-01 |
| Follicular-VS-Normal |
4.22084589501992E-12 |
| Other-VS-Normal |
8.197700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
5.908000E-02 |
|
|
